Cargando…

Artesunate and Dihydroartemisinin Inhibit Rabies Virus Replication

Rabies is caused by infection of rabies virus (RABV) and remains a serious threat to the global public health. Except for the requirement for cold chain and high cost of human rabies immune globulin, no small molecule drugs are currently available for clinical treatment of rabies. So, it is of great...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Jun, Zhang, Yue, Wang, Yang, Liu, Qing, Li, Jiesen, He, Hongling, Luo, Yongwen, Huang, Shile, Guo, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930525/ https://www.ncbi.nlm.nih.gov/pubmed/33661488 http://dx.doi.org/10.1007/s12250-021-00349-z

Ejemplares similares

Rabies Virus-Induced Autophagy Is Dependent on Viral Load in BV2 Cells
por: Wang, Yang, et al.
Publicado: (2021)

TRIM25 Suppresses Rabies Virus Fixed HEP-Flury Strain Production by Activating RIG-1-Mediated Type I Interferons
por: Zhang, Boyue, et al.
Publicado: (2023)

TRIM21 Promotes Rabies Virus Production by Degrading IRF7 through Ubiquitination
por: Zhang, Boyue, et al.
Publicado: (2023)

Interleukin-25 enhances humoral immune responses caused by the rabies virus
por: Zhang, Yue, et al.
Publicado: (2022)

Dihydroartemisinin Inhibits mTORC1 Signaling by Activating the AMPK Pathway in Rhabdomyosarcoma Tumor Cells
por: Luo, Jun, et al.
Publicado: (2021)

Population Pharmacokinetics of Artesunate and Dihydroartemisinin following Intra-Rectal Dosing of Artesunate in Malaria Patients
por: Simpson, Julie A, et al.
Publicado: (2006)

Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects
por: Tan, Beesan, et al.
Publicado: (2009)

Deoxynivalenol Mycotoxin Inhibits Rabies Virus Replication In Vitro
por: Liu, Qian, et al.
Publicado: (2023)

The Deoptimization of Rabies Virus Matrix Protein Impacts Viral Transcription and Replication
por: Luo, Jun, et al.
Publicado: (2019)

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria
por: Morris, Carrie A, et al.
Publicado: (2011)

Stereoselective Access to Antimelanoma Agents by Hybridization and Dimerization of Dihydroartemisinin and Artesunic acid
por: Botta, Lorenzo, et al.
Publicado: (2021)

Rhabdovirus Infection Is Dependent on Serine/Threonine Kinase AP2-Associated Kinase 1
por: Luo, Jun, et al.
Publicado: (2020)

Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults
por: Fehintola, Fatai A., et al.
Publicado: (2012)

Phosphoprotein Gene Contributes to the Enhanced Apoptosis Induced by Wild-Type Rabies Virus GD-SH-01 In Vitro
por: Tian, Qin, et al.
Publicado: (2017)

Phosphoprotein Gene of Wild-Type Rabies Virus Plays a Role in Limiting Viral Pathogenicity and Lowering the Enhancement of BBB Permeability
por: Long, Teng, et al.
Publicado: (2020)

Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects
por: McGready, Rose, et al.
Publicado: (2012)

An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
por: Valecha, Neena, et al.
Publicado: (2010)

In vitro and in vivo inhibition of rabies virus replication by RNA interference
por: Durymanova Ono, Ekaterina A., et al.
Publicado: (2013)

iTRAQ protein profile analysis of neuroblastoma (NA) cells infected with the rabies viruses rHep-Flury and Hep-dG
por: Yang, Youtian, et al.
Publicado: (2015)

Development of a colloidal gold-based lateral flow dipstick immunoassay for rapid qualitative and semi-quantitative analysis of artesunate and dihydroartemisinin
por: He, Lishan, et al.
Publicado: (2014)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
por: Valecha, Neena, et al.
Publicado: (2010)

Correction: An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia
por: Valecha, Neena, et al.
Publicado: (2010)

Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India
por: Gargano, Nicola, et al.
Publicado: (2012)

A Simplified Liquid Chromatography-Mass Spectrometry Assay for Artesunate and Dihydroartemisinin, Its Metabolite, in Human Plasma
por: Teja-Isavadharm, Paktiya, et al.
Publicado: (2010)

Efficacy of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015
por: Plucinski, Mateusz M., et al.
Publicado: (2017)

Genome-Wide Transcriptional Profiling Reveals Two Distinct Outcomes in Central Nervous System Infections of Rabies Virus
por: Zhang, Daiting, et al.
Publicado: (2016)

Viperin inhibits rabies virus replication via reduced cholesterol and sphingomyelin and is regulated upstream by TLR4
por: Tang, Hai-Bo, et al.
Publicado: (2016)

Amino Acid Mutation in Position 349 of Glycoprotein Affect the Pathogenicity of Rabies Virus
por: Luo, Jun, et al.
Publicado: (2020)

Trim25 restricts rabies virus replication by destabilizing phosphoprotein
por: Yuan, Yueming, et al.
Publicado: (2022)

Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
por: Morris, Carrie A, et al.
Publicado: (2011)

Efficacy of artesunate–amodiaquine, dihydroartemisinin–piperaquine and artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger
por: Grandesso, Francesco, et al.
Publicado: (2018)

Rabies viruses leader RNA interacts with host Hsc70 and inhibits virus replication
por: Zhang, Ran, et al.
Publicado: (2017)

Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC
por: Onyamboko, Marie A, et al.
Publicado: (2011)

A comparison of the duration of post-treatment protection of artemether-lumefantrine, dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated malaria
por: Bretscher, Michael T, et al.
Publicado: (2014)

A Randomized Comparison of Dihydroartemisinin-Piperaquine and Artesunate-Amodiaquine Combined With Primaquine for Radical Treatment of Vivax Malaria in Sumatera, Indonesia
por: Pasaribu, Ayodhia Pitaloka, et al.
Publicado: (2013)

High cure rates and tolerability of artesunate–amodiaquine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania
por: Mandara, Celine I., et al.
Publicado: (2019)

Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia
por: Roesch, Camille, et al.
Publicado: (2020)

Adeno-Associated Viruses Serotype 2-Mediated RNA Interference Efficiently Inhibits Rabies Virus Replication In Vitro and In Vivo
por: WU, Hong-Xia, et al.
Publicado: (2013)

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine
por: Byakika-Kibwika, Pauline, et al.
Publicado: (2019)

Function of Host Protein Staufen1 in Rabies Virus Replication
por: Liu, Gaowen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pup2rdkdjgoatb46beu7nu9832